Doc 0000151512

.... a. Stnce St-1rt. o£·2~;-tJeet·. Thl~ portion of. th¢ s-vmm:lry covers a p~rlod fro:-ll July 1, 1951 t:-. january I, 1953. A: stated above; th~ obj~ctlve of the project Is to find a svnth~ttc drug rs which as effecttve and as safe from the polnt of view of human toxicity and addiction llabll1ty as Is codc(ne. The d~ug I, needed because, alth=ue~ adequate synthetic substttut~s for morphine are available, no such drug of the codeine typP. ls.avallable. Since 75 per c~nt of th~ needs for narcotics are for code1ne rather then for morphtne, this means that we must contlnue tti Import and ~tockp1fe opium until an substitute for codeine has been • ac;l~quate d'=velo~~d . { Th e r o I e o f t he N 11'·/H A-dd t c t I on R-'e s e a r c h Ce n t e r 1 n t h r s r e s e a r c h i s ·r related to studying the Bddlctlon l1abil1ttes of new drugs. The ·" . ; of anti must ev~luat!on an~lg~slc ~nd t~ssive ~ff~ctz nac~ssartly Methods U$ed 1n studying addiction of the new Jt~bilttl¢$ have been described in In the project analg~stcs d~tdll clz~criptions Natlonat Re!carc~ Ccunctl. ~hen such drugs are rice1ved, the hum~n .. '· pharmacaJ8si of fhe compound, lncludcs ion of ~hlch d~ferminat i~s effects en blood pressure, minute volume, r~sptratory t~mperature 1 pupillary size, etc., is carrted out. After this Is ccmp!et~d, . the effects of the drug on th~ b~havior of fermer morphine addlctt are evaluated by 4dm1n1ster·lng the drug Jn amounts based on ~he results oLtatned tn If the th~ pharmacol~glcJI exp~rlments. dr~g behavJor resembling that seen after morphine or codeine, Induce~ tt Is llkely to have addiction llablltty. The ability of tht! drvg to relieve and to prevent of symptoms of abstinence th~ ~pp~arance from morphine Is next Jn tents strongly addicted to studl~d ~at morphine. If the drug. relteves or suppresses \lbstlnence, lt 1s judged to have addtctton In such the ll~bllttv. exp~r1ments, ... dose to relieve or suppress abltlnence and the requJr~d d~grce 1 of raftef or supRresslon, are Indices for comparl•~~ wfth the ::r standard drug, codefn¢. tr When ~n e~pecr~l!y promising qrug ts available-, h st!Jdtcd b'.' t~!! di:-~ct e::fdh::tioJ'l tcchntc. __ Thl: Involve£ the administration o f a s c end I n g do s e s t The image displays a stylized graphic of a vault door on the left, with a neon blue glow emanating from it. To the right of the vault is white text on a black background. The text is mostly in a blocky, sans-serif font, with the title "THE BLACK VAULT" in a stylized, handwritten font at the top. Below the title, the text explains that the document was obtained from "The Black Vault," an online database of declassified government documents, specifically mentioning its housing in the "MKULTRA/Mind Control Collection" and its origin from the Central Intelligence Agency (CIA). A hyperlink to "http://mkultra.theblackvault.com" is provided in yellow at the bottom of the text. No photographs, handwritten annotations, stamps, forms, diagrams, tables, redactions, or visual evidence of experimental procedures are present. The document appears to be a typewritten research report with handwritten annotations. A large number, possibly a page number, "22" is visible at the top right. There are also handwritten markings at the bottom right corner, including what appears to be a document identifier "A-79". The text describes research on synthetic drugs and their addiction liabilities. No photographs, diagrams, stamps, or forms are visible on this page. There are no redations or evidence of experimental procedures or equipment. d~grce 1 of raftef or supRresslon, are Indices for comparl•~~ wfth the ::r standard drug, codefn¢. tr When ~n e~pecr~l!y promising qrug ts available-, h st!Jdtcd b'.' t~!! di:-~ct e::fdh::tioJ'l tcchntc. __ Thl: Involve£ the administration o f a s c end I n g do s e s t o f o rm e r a d d t c t - vo I u n t '! e r s o v e r- p ~ ,. 1o d s o f -t' tim~ ronging 6~t~een 30 to,I~O days. -Durlng the addTctton pertod, suitable measuraQents are cdrrled out to detect end the cvalua~z development of tolerance. Finally, drug$ are withdrawn abr-uptly Th~ drugs studied beh'J'i?\?:n I July 1951 dnd I January 1953 dim~thvlamtno butyrate, J-2thylamico 1:1-£21 dlthltnyl)-but-1-ene hydrochlorid~, and 3-di~t~ylamlno J:t f2' dithienyll-!:>ut-1-enc hydrochl::;rfdc. ·- -. .;~····.·.•:.; ~ --•. : ..... ~-. .-,.. - '"··.,.. ".· ..... •' .:•·:,-:. J.., " . or too I to posstble ~reat ~ddtcilon f~btlrtv b~ conJtd¢r~d·OS substftutes for cod~lnc: LDrom~ran,! 3~m3thyl ether of Dromoran, 3-ethylmethylamlno-1:1-t2'dlthl~nyl>-but-1-en~, 4nd 3-dtethyl~mino- --· 1:1 f2'dlthlenyl~but-1-ene. The following drugs have sufflclcntly low toxicity and sufficiently low addlct1on liabiltties to be t reg~rded as pote~ttat cod~lne substitutes: d Drornora~, 3-mcthyl c t he r of Dr omo ran , &, 2_. a n d ! 2 : 2 -d 1p h en v 1-a m1 no c t hy l v cd era t ! , dl-2:2-dtphanvl-4.;.dlrnethvlamino b.utyrdte. Of these drugs, the £ 3-methyl ether of tc be the most promistng Dro~oran app~ars and Is under test for antltusstve This compound cll~tcal v~lue. Is~ 'r• r how~v2r~ known to ~e lnaJf~ctiv~ ~s an anal~es ~c. ~ Orcmoran ha~ been discarded, since lt;'ls not an·· ~ffcc_tlvd antitusst.v~. It has b~en rccor.1mendad that /prelll:linery-:-clir.icat tc3ting be begun with 2,2~dt~h~nyl-4-dimethylarntno butyr~te. b. Results D~rlna Current ~~oortln~ Pcr1cd. During th~ first six months of the rEporting thz was ~~riod proj~ct ftnanc~d I Julv ·195:;, lt has_be~n findnccd by th~ Office of N,J\·Nl Rcscdrch. Th~ report include:z results obtained during both perirJd.s of ti;:-.~. The used were wtth m~thod$ ld~nfic&l thos~·d«scribed abov~. "-/' A 7 / . ',.!..._ l.- I / The drugs·have t¢stedt foll~~ln9 be~n 21., £. Ci J ~Snd 12,~-dfph~nyl-4-dim~thyll:nlno val~Zrdte. Work with was completed during the first six the!~ eomp~unds months of the year. The· results were Identical wlth the tentattv~ results reported tn the last progress report. All of these This page primarily consists of typed text describing pharmacological experiments related to drug addiction and abstinence. There are no photographs, forms, diagrams, tables, or stamps visible. The only handwritten annotation is a small, illegible "A-78" in the bottom right corner. There are no apparent redactions or visual evidence of experimental procedures, equipment, or facilities. The document appears to be a purely textual report. 7 / . ',.!..._ l.- I / The drugs·have t¢stedt foll~~ln9 be~n 21., £. Ci J ~Snd 12,~-dfph~nyl-4-dim~thyll:nlno val~Zrdte. Work with was completed during the first six the!~ eomp~unds months of the year. The· results were Identical wlth the tentattv~ results reported tn the last progress report. All of these compounds, In doses of 60 to 75 mg., Induce slight pu~tltary . constrtcttcn, sltsht re:p1ratory depression, and resemblino bch~vtor that seen after the of small amounts of ~dmlnlstratton morphin~. :·~· No untoward side eff'~:::ts were obs~rved with the dos~s used. All ... of the compounds,were relatively Ineffective in suppresslng :~ abstinence from morphine \1nd 1u dged to have low ocl::ftction - ar~ lleblllty. The cl:x t roroJ _d tory CCrrl.JOUild app~t.~rs to. bf~ the most / erfcctive. (rl;:i i:nlnJry·cci tnical . -. te~tin:i.... ,"}f the dcxtro- and I evo• rotatory Isomers Is be1ng recommended to the Drug Addiction / Comm t t tee. (2J il This 2,2-dlph~nvl·4-dimethylamino butyr~t~. compound has propzrth::.s res<Imbling those described under l I} bbove. but h even i;zss potent. Pr·ziiminarv ciinic.sl trial rr!<'5Y tie warranted. . . (3) 3-cthvlrncthylanl~o-I:J-t2'dithtenvf )-but-1-ene. T~ls drug i~ th~ ~rototypc of a co~pletcly ne• cia~: of synth~tic analgesic~ whtc!l was dhcov~red tn Grszat Sri·f.Hn. In dcs<:s of '"'0 t •() ms., ·,t pupi llJry coin tr tct ion, d!!press ion of .;; 0 C.v. ; . i . . ~ .. respiratory rate anJ mlnuic ~olume, and 1nducts behavlo~ ~trongJy resembllng that sc~n after 6dmtn1str~tlon of IS to 30 mg. of morphl~e.sulfitc. The drug ls trrlt5ting to the skln and ls broken down tn the body to unknown sulphur-containing cc~p~unds which cause_mark~d discoloratton of the urln¢. tn som~ pat tents~ mental. redcttons either of p~cultar ~on3tsting hypn~goglc delusion~ or true hal,ucinattons but ~it~ matnt~nance of Joslght v~re observed. drug Is v¢ry effectlve lo·supprcssing abstinence Th~ from morphine. During ·l period of 30 day~ ~xperlm2ntal addlctlon 1 purttal tolerc'Hlcc~~~aa developed. Abstlnenc~ was prel!l'pttatcd h'J ,, N-~~Jvlnormorphlne ~nd, on &brupl wlthdrawal, a d~ft"ttr ab:tinence 'I syndrome was observed ab,ttnence from wh1~h r~sembt~d ruorphln~, ex:ept fc:lr time C<Jurte~ Thts drug:.was judsed to be too toxic and to have addlctton liability to a good t~o~tgh b~ canstd~red subst1tute for codelnc.n ·furtherrnor~, tt was ·relatively ln~ffectiv~ given orally. wh~n { 4 J 3-d 1 z t !n' 1a m 1 no 1 : t - ( 2 f d it h i en v I } toxic and to have addlctton liability to a good t~o~tgh b~ canstd~red subst1tute for codelnc.n ·furtherrnor~, tt was ·relatively ln~ffectiv~ given orally. wh~n { 4 J 3-d 1 z t !n' 1a m 1 no 1 : t - ( 2 f d it h i en v I } - b u t -1-en c • ts• Thls member of the Alpha-1-methadol~. m~thadone s e r I e s i s a very pot c n t drug • I n do s z s o f 3 0 to 6 0 mg • I r i nd u c ~ s . pupillary constric} ion, rezplratcry d!<!;::>r.ess ion, etc. These eff~cts quite slowlv.and still 72 hours admin- ap~ear ar~ ~vident fo!Jowi~g tstration of the drus elih€r subc~taneously or orully. tt ts ')( •' .1.:1! ... ,.--.... ' \ '·. ~ ·~.· · - . t~".'· .~ · ! . ·.t·;t'," " ·.-' ";,· exfrem~:ly ivi~,n ~!Jst in~nee effect supo;-ess lng (rom morph 1 -.. n-~. ... ' The drvs Is judg<:d to bri! teo to'<l<: and .to h~ve too high adcltc:ffon ltabt!tty ~o bg r~garded ~$ a promising :ubstttut~ for codein~. (OJ Beta-d-Qcetylmethadol. This compound Is sfmllar to (5). Its propertlci are such that it i: not regarded as a promising substitute for codeine. 17). Dextro- levorotatory 2,N-dlmethvl-3-hydroxy a~d morpblnan. The dextrorotatory form of this compound is quit~ Inert In man. I( do~s not ~roduse morphlne-llke effects and ts completely In reltevtng and suppressing ab$tinenc: tn~ffcctlv~ from morphine. ~o untowurd toxfc effect~ ~¢r~ ob$2rved with . do3cs rengi?g as ~tsh e~ 75 mg. sub~u~an€cusly or orally. The ,. gtven tn dosc:s of 30 to 60 mg. e-rth~r hy~cderrnically or ore! Jy. It is falrlv-effectlv~ 1~ $uppresslng ~bstincnee from.mor~htne. The !ev~rotatory form J~ judsed to have srzat€r addiction I Jabl~ity than th~t of codeine. However, in tha event that~ methyl Drc~oran Is not found to be an effective antitussive esent, rccc~~cndJtlon for clinical trial of agent would be as thl~ ~arrant~cl~ ~iace, (8 l i.Hxivre$ of N-AI iy lncrmorph ine .~nd i/.o-r;:1h in~ .. Mixtures of thesz drugs hsve been studied dt the F~com~endation of thz Drua Addiction Co~~tttee ~~ th~ bcg;n~t~G deslsn~d to determine whe}h~r or not the addJctlon liability of /(-7~1 - th~ more powerful :ypt~~t)cs c~n b~ ottenuated b~ th~ addftlon of N4!lln~ or other mcr~hlnc dnt~sonists without serlbusly tmpalrlng t he rap c u t The image is a scanned document page containing typed text. There are no photographs, diagrams, or tables. Handwritten annotations are present in the bottom right corner, reading "A-77". There are no visible official stamps, signatures, or redactions. The text discusses various drugs and their potential as codeine substitutes, along with mention of clinical testing and financing of related projects. The document is a typed page with a handwritten annotation in the bottom right corner that appears to be a page number or document identifier: "A-76". There are no photographs, official stamps, forms, diagrams, or tables. There is no visible evidence of experimental procedures, equipment, or facilities. The text describes the testing of various drugs for their effects, including pupillary constriction and respiratory depression. been studied dt the F~com~endation of thz Drua Addiction Co~~tttee ~~ th~ bcg;n~t~G deslsn~d to determine whe}h~r or not the addJctlon liability of /(-7~1 - th~ more powerful :ypt~~t)cs c~n b~ ottenuated b~ th~ addftlon of N4!lln~ or other mcr~hlnc dnt~sonists without serlbusly tmpalrlng t he rap c u t I c e f f e c t s • T h e f o I i o \:1 t 'n g r;d x t u r ~ ~ · h a v e b c e n s t u d t e d : I to 10 (J mg. to each 10 mg. morphine>, I to 5 tl mg. Nalltn~ to each 5 mg. of morphine}, and I to 3 (I mg. Nal line to N~lllne each 3 mg. of morphln~). When administered subcutaneously, d~vclopm~nt of.mor~htn~-ltke euph6rta I~ former ~orphine eddt~ts ts blocked with all th~se mixtures for p~rlods rangtng b~twecn to- . 2 3 hours. The higher the proportion of Nalllne tn the mlxtur~ the more effecttve ts the blocklng and the lonser It pertlstso ~- Mlos ls Induced by/m~rph lne_ is pilrt J ly anfagonl:zed by these mixtures • . Depression of respirator~ mtnute volum~~ ho~eyer~ I~ when the drugs are adMin_J'stered simvtte!i~ou-;ly. The!e mtxtvr::::s or abitinence Intense, pr~clpltatc abstlnen~e mak~ ~ore rath~r / than 4t. During direct addiction experiments, pattcnts r~l1eve on all mlxtures bitterly that the drug did not th~e~ ccmplatn~d have the de$lred eff~cti, that it hdd no nktckw and fhdt tt dtd no t m J L II" . c 1• t1.1 e !":'1 nh' • s.h • n De$plte t~ts, evidence of mor~hine-ltke excessl~e somnolcne~, etc •. After a· few days of chr~nic ad~lnls- . t r a i· ton of t he r:li x h.J r ·? , pro f u s ~ HH! a t i r: !; '<t<'HJl d o c c v r .:l f t e r e :J c h re~p~zar following t~c next injection. ~~fi~nts a~~o co~pi0Jn~d of weird dreams. On abrupt withdrawal of the mixture, some pat1e~ts experfenc£d haltuclnatlon~ during the first w~lrd 24 hours of' abstinence; th::rcaft\!r,. mild morph1n~~~~~c ab1ttnence was observed •. The Intensity of abstinence after withdrawal of the mixtures was than fol lowlng wlthdrawal of morphlnz. l~ss Experiments w1ih th~sc mixtures have b~cn encouragtng~ They appear to be relatively safe and they could not be abused by drug addlcts. 24 hours of' abstinence; th::rcaft\!r,. mild morph1n~~~~~c ab1ttnence was observed •. The Intensity of abstinence after withdrawal of the mixtures was than fol lowlng wlthdrawal of morphlnz. l~ss Experiments w1ih th~sc mixtures have b~cn encouragtng~ They appear to be relatively safe and they could not be abused by drug addlcts. so their addt~ticin ltebillty I~ judged to be low or non-ex Is tent. P10wever, cart a In drawbacks are apparent l both morphine and Nalltne c:r~ relative.ly Ineffective when admintstcr~d orally. It ts also unknown ~hether tb~ un~t~~s~~t effects observed j':,. during chronic admlntstrat-ton o( J.arge "addicting" do::c~ would . /' cecur t£ th~ doses-were held tn the usual therapsutic ra~se. lf / t h 1s o c c u r s , t h e 1:11 x i u r ~~ c o u I d no t be ~s e d c I 1n 1c a I I y • (9) 4-4-Dlphenvi-6-Dimethylamino~H~~anone-3. This ~ memb~r of th~ m~thada~c s~rle~ tnduc~s ~tld morphine-like effects ~hen edmin!st~r~d tn doses of 60 mg. either hy~odcrm~~~~ly or orally. ~h serlcus toxlc effects have been ob$erved with these _9bserv~d following administration of 60 to 75 mg. ~7pcdzrm1celJ~ . to p . ~tient' uith sever~ . symptoms of wtthdr~w~l from mor~hln£. regard~d es posstbly v~ry promising fr~m the point of view of lo~ ~dd!ction ll!~lll{y. (I 0 1 ~ , J..:me ..t h~ 1-4-ph e11y 1~ 4-ca rbo t hox-yaa zocyc l oh~pt l!n e. Thfs compound ls a memb¢r of th~ demerol s~rl~s. Dos~s rungtng up to 150 mg. subJ€etlve detect subcut~neous!y induced·n~ither ~or able effects in nontolerant morphlnc addicts. obj~cttve for~er whn€ 2 pat tents· who were strongly addieted to morphine H~H'f\!Vcr, received ISO mg. of the drug ln a suppressive serious experlm~nt, toY.Ic r.,cnif-:l·tco. by dizziness, blurring of vision,. r~ectl~ns· onxlety, el~vated blood pre:eure and, In one patient, :tgns of pulmonary edema en-s"ued. Work with the compound has b€en suspended p 2 n d I n g f u r t h e r a n i me ll to x t co I o SY a t t h e IJ n t v e r s tt y o f M1 c h t g a n • PlANS FOR FUTUg£:1 ... lmr:'ledle:!'_!:.• During t'he comJ~g 'lx months we hcpe to c:omplai·z work on th<: drugs llsted tinder Items f7L through fl01 o:bove. In .. ~dd1tlcn, ~e plan to The document is a typed page with dense text, likely an excerpt from a report. There are no photographs, diagrams, or tables present. However, there is a handwritten annotation in the bottom right corner: "A-75". Additionally, there are small, scattered dots or flecks that appear to be damage to the paper, and faint circular marks that might be the remnants of tape or adhesive. A few characters at the very top are partially obscured or faded, and some text is slightly blurry, particularly in the second paragraph related to the drug's effects. The image is a scanned page of a typewritten document. There are no photographs, diagrams, or tables. The only handwritten annotation is a numerical designation "A-74" in the bottom right corner. There are no visible official stamps or redactions. The document appears to be a scientific or technical report, discussing the properties and effects of various drugs, specifically in relation to addiction and as potential substitutes or treatments. IJ n t v e r s tt y o f M1 c h t g a n • PlANS FOR FUTUg£:1 ... lmr:'ledle:!'_!:.• During t'he comJ~g 'lx months we hcpe to c:omplai·z work on th<: drugs llsted tinder Items f7L through fl01 o:bove. In .. ~dd1tlcn, ~e plan to t~v~sttgate the properties of the following morphine ant4gof.ist~: (I} N..AIIylnordiac¢tylmorphine, (2} N-?ropyl- dlhydronormorph ln~, (3 i dextr~rotator~, N-A-llyl~ordromor.~n, (4) l~vo- rotatory N-AI lylnordromoran, CS) levorotatory 3-m~thylether of N-AIIylnordromoran. lt is hoped that some of thes~ antagonists ~111 b~ eff~cilvc orotly. ln the event that .s uch an antas~nlit . Is found, tf1e effects of oral aJ:n.inistratlon of the antasor:tst .. when comblnad wtth methadone, Dromoran and! ether of 3-~~thyl Dromoran ~itl b~ ~tudled ln the hope of d~v~lcping an crdliy ·with a potent synthetic orally effective analgesic druo. Such ~nd r.< i x t u r?. s s h o u l d I l k e m l x t u res of mort' h t n e 4 n d Nd 1 I I r. e , h J v c 1 # • ..... • • ~ ·• reduced addfctlon lidbiiJty. Wfl ~·!~plan to O;J<Hl cl nC"Jt' Gp.?.-~w<:h f~ th~ probl~m and to inv~s~lgate t~e posstblltty.of comblnfng codeln~ with a metabolic ~tocktng ~gent, beta-dt¢thylamino~thyl­ propylac~tat~. This ccm~ound Is r~portcd to Increase the tntc~slty of effect and the length of action of~ number of onalgc;fc druss. Combining lt with codeln~ w~uld.represent on~ way of lncreastng ~~ng-renn~ ?fa~~. W~ tnt£nd to continua the secrch for an ad-equate ~ubstltuh: for codeine u.nttl "drug ts found which ls ... ~ Counc: tl to fu If' n-1 a II the_ n'l'ces_;; a rv requ tr~mt:.n ts. . '..- ct the ~rc}~ct due.tc lack of fund~ ~o~IJ cau~~ ~or~ to ce~se prior to of thti roJ!. th~ ~ttatnmcnt . ..... ~;:, ,"'CJRTS A'-D PU3l I CAT 10'!5 (!)ur ing (;urr~rd report tng pzr ted i i • Add!ction liaollity .!..&: of Dit!t!<.:"ny!butyl.arnln!O!~. F.-sd~raft~n ?roc .. 33-3 C·.~-lr.) 1953. g 2. Isbell, H., Qnd Fraser, H.f.: A=ttons and Addiction Li~blliti~~ . ~sb~IL ~~... and r-~as-::r_ H. F.: Ac·Hon.s ~nd /\ddiction l..i:Jbl;nv ~ - of tii:~ Dlthlt'!ny!h.:tcnyh:1h;Js In :·,;;na " ,. {..t :. r. :) -~ ~ • . r:l ,.., ...,. .., . .-.. .·.. ' r• :• •• I! • !i' ! I " < • > • . \. . , ' The document is a typewritten page with handwritten annotations. The typewritten text discusses the effects of combining Nalline with morphine in experiments. There is a handwritten annotation in the bottom right corner of the page that appears to be "A-73", possibly a document or page number. No photographs, official stamps, forms, diagrams, tables, or redacted content are visible on this page. r-~as-::r_ H. F.: Ac·Hon.s ~nd /\ddiction l..i:Jbl;nv ~ - of tii:~ Dlthlt'!ny!h.:tcnyh:1h;Js In :·,;;na " ,. {..t :. r. :) -~ ~ • . r:l ,.., ...,. .., . .-.. .·.. ' r• :• •• I! • !i' ! I " < • > • . \. . , ' . < . • . I 21 ' , \; · : e i f ..J ) io 4 ! t • ,: ; . ~ . , , , ... I . • I . . . . ._ ,, " , ' s 1 ~ - t •') .,. . ~ I - . • flnpressJ. • D Y j""h - l : - r r • r - . c -, ~t- . - . - .. r l - - ~; o -c~ . : , . .. . . z "" .1, .o 1. .~. . .~. • . . , ... . .,. .. .a . . - . , y •- -; r ; - . = - . . ... - . - /,.. :/ _ 1 - ...... - - _ .. ; - . 1 ? / . t; ·~ ll '~ , ..... The document is a typed page with handwritten annotations. The typed text discusses the effects of drug administration and abstinence, with a section specifically detailing a chemical compound numbered "9". There are no photographs, diagrams, or forms. Handwritten marginalia include the number "A-72" in the bottom right corner, suggesting a page or file number. The text appears to be of moderate to poor quality, with some words partially obscured or appearing faded. There is no visible evidence of experimental procedures, equipment, or facilities. The document is a declassified CIA file page containing typed text detailing research on a compound. In the bottom right corner of the page, there is a handwritten annotation "A-71" with some dots below it. The text itself describes the properties and effects of a drug and outlines future research plans, including investigations into various "morphine antagonists." There are no photographs, stamps, forms, diagrams, tables, redactions, or visual evidence of experimental procedures visible on this page. The document appears to be a typewritten report with handwritten annotations. The main content is a narrative describing research into reduced addiction liability and drug substitutes, followed by a numbered list of "REPORTS AND PUBLICATIONS." At the bottom right, there is a handwritten signature that reads "Morris Isbell, M.D." with a handwritten addition of "A-70" and the title "Director of Research." There are no photographs, diagrams, schematics, or official stamps visible on this page. There are no obvious redactions in the visible portion of the document.